Insufficient scRNA-seq data for expression of LCMT2 at single-cell level.
Insufficient scRNA-seq data for expression of LCMT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 454.79 | 2630 / 2642 | 100% | 8.82 | 705 / 705 |
prostate | 100% | 574.58 | 245 / 245 | 99% | 8.23 | 499 / 502 |
ovary | 99% | 501.52 | 179 / 180 | 100% | 8.11 | 428 / 430 |
breast | 100% | 535.12 | 458 / 459 | 99% | 10.04 | 1109 / 1118 |
thymus | 100% | 590.35 | 652 / 653 | 99% | 8.18 | 597 / 605 |
skin | 100% | 608.92 | 1808 / 1809 | 97% | 8.48 | 460 / 472 |
esophagus | 100% | 596.09 | 1439 / 1445 | 97% | 5.95 | 178 / 183 |
kidney | 100% | 457.25 | 89 / 89 | 96% | 6.46 | 865 / 901 |
stomach | 99% | 505.75 | 357 / 359 | 96% | 4.84 | 275 / 286 |
uterus | 99% | 603.63 | 168 / 170 | 96% | 7.37 | 442 / 459 |
pancreas | 98% | 331.42 | 322 / 328 | 96% | 4.82 | 171 / 178 |
bladder | 100% | 503.95 | 21 / 21 | 93% | 4.96 | 469 / 504 |
adrenal gland | 100% | 681.21 | 258 / 258 | 93% | 6.29 | 214 / 230 |
intestine | 100% | 530.38 | 963 / 966 | 93% | 4.94 | 491 / 527 |
lung | 91% | 374.15 | 526 / 578 | 97% | 5.93 | 1125 / 1155 |
liver | 100% | 332.78 | 226 / 226 | 80% | 3.30 | 324 / 406 |
spleen | 100% | 645.70 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.50 | 1 / 1 |
adipose | 100% | 507.22 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 446.81 | 1328 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 343.43 | 795 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.20 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 4.98 | 28 / 29 |
heart | 96% | 364.62 | 829 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 7.15 | 75 / 80 |
peripheral blood | 64% | 303.51 | 592 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031591 | Biological process | wybutosine biosynthetic process |
GO_0006400 | Biological process | tRNA modification |
GO_0030488 | Biological process | tRNA methylation |
GO_0005737 | Cellular component | cytoplasm |
GO_0008175 | Molecular function | tRNA methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LCMT2 |
Protein name | Leucine carboxyl methyltransferase 2 tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase) |
Synonyms | TYW4 KIAA0547 |
Description | FUNCTION: Probable S-adenosyl-L-methionine-dependent methyltransferase that acts as a component of the wybutosine biosynthesis pathway. Wybutosine is a hyper modified guanosine with a tricyclic base found at the 3'-position adjacent to the anticodon of eukaryotic phenylalanine tRNA (By similarity). May methylate the carboxyl group of leucine residues to form alpha-leucine ester residues. . |
Accessions | ENST00000567039.1 O60294 H3BU01 ENST00000305641.7 |